Six-year survival of patients with severe respiratory failure treated with long-term oxygen therapy at home
https://doi.org/10.18093/0869-0189-2005-0-1-81-83
Abstract
Long-term oxygen therapy (LTOT) improves survival of patients with chronic obstructive pulmonary disease (COPD) having severe respiratory failure and chronic hypoxemia. In our study 51 patients received LTOT at home via concentrators (34 males, the mean age, 65.5 ± 7.8 yrs; 17 females, the mean age, 62.8 ± 4.1 yrs). Of them, 37 (72.5 %) survived 6-year period and 14 died (13 males and 1 female).
Causes of death were acute respiratory viral infection (in 1 patient), insult (in 1 patient), chronic heart and lung failure (in 12 patients). Survival of patients with chronic restrictive pulmonary diseases was not longer than 3 years.
A control group included 45 COPD patients with severe respiratory failure not receiving LTOT (30 males, the mean age, 66.3 ± 8.5 yrs; 15 females, the mean age, 69.1 ± 4.6 yrs). Of them, 16 survived 6 years and 29 died (5 females, the mean age, 72.6 ± 3.6 yrs, 24 males, the mean age, 67.8 ± 5.2 yrs).
So, LTOT at home improves survival of COPD patients with severe respiratory failure.
About the Authors
A. R. Tatarsky
Российский государственный медицинский университет; Городской пульмонологический центр
Russian Federation
Russian Federation
A. E. Baskakova
Российский государственный медицинский университет; Городской пульмонологический центр
Russian Federation
Russian Federation
References
1. Длительная кислородотерапия в домашних условиях: Метод. Рекомендации / Чучалин А.Г., Третьяков А.В., Сахарова Г.М. и др. М.; 1996. 4—6.
2. Оптимальная оценка и лечение хронической обструктивной болезни легких. Согласованное заявление Европейского Респираторного общества. Рус. мед. журн. 1998; 3: 14—15.
3. Чучалин А.Г. Хронические обструктивные болезни легких. М. 1998. 11—38.
4. Чучалин А.Г. Клинические рекомендации по лечению больных хронической обструктивной болезнью легких. М.; 2002. 53—58.
5. Barjnoux C., Pepin J.L. et al. Long-term oxygen therapy at home following of medical prescription and compliance. In: ANTADIR Activity of association system: Abstracts 1992-1994. Paris; 1996. 20.
6. Chailleux E. Pronostic index of survival for COPD on long-term oxygen therapy, a study of 1603 patients from ANTADIR Register. In: ANTADIR. Activity of association system: Abstracts 1992—1994. Paris; 1996. 16—18.
7. Chailleux E. Home treatment for chronic respiratory failure in FRANCE. Data from ANTADIR Register. In: ANTADIR. Activity of association system: Abstracts 1992-1994. Paris; 1996. 14—15.
8. Chailleux E., Taytard A., Paramell B. et al. Characteristics of patients prescribed long-term oxygen therapy outside prescription guidelines. ANTADIR FRANCE. Eur. Respir. J. 1996; 9 (suppl. 23): 324.
9. Erban J., Homolka J. et al. Three years of long-term oxygen therapy in the Chez Republic. Eur. Respir. J. 1996; 9 (suppl. 23) 324.
10. Medical Research Council. Working Party. Long-term oxygen therapy in chronic bronchitis and emphysema. Report. Lancet 1981; 1: 681—685.
11. Nocturnal Oxygen Therapy. Trial group. Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease. A clinical trial. Ann. Intern. Med. 1980; 93: 391—398.
12. Observatoire 1996. ANNUAIRE statistique ANTADIR FRANCE. Paris; 1996. 19.
13. Pepin J.L., Levy P. et al. Are patients education and technical and medical follow-up. Able to increase compliance with therapy in chronic respiratory failure patients? In: ANTADIR. Activity of the association system: Abstracts 1992—1994. Paris; 1996. 22.
Review
For citations:
Tatarsky A.R., Baskakova A.E. Six-year survival of patients with severe respiratory failure treated with long-term oxygen therapy at home. PULMONOLOGIYA. 2005;(1):81-83. (In Russ.) https://doi.org/10.18093/0869-0189-2005-0-1-81-83
Views:
451
Email this article 